These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. History of the cholesterol controversy in Britain. Thompson GR QJM; 2009 Feb; 102(2):81-6. PubMed ID: 19042967 [TBL] [Abstract][Full Text] [Related]
4. Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S). Strandberg TE; Pyörälä K; Cook TJ; Wilhelmsen L; Faergeman O; Thorgeirsson G; Pedersen TR; Kjekshus J; Lancet; 2004 Aug 28-Sep 3; 364(9436):771-7. PubMed ID: 15337403 [TBL] [Abstract][Full Text] [Related]
5. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals. 2003. Shepherd J; Hunninghake DB; Barter P; McKenney JM; Hutchinson HG Atheroscler Suppl; 2004 Oct; 5(3):115-23. PubMed ID: 15531284 [No Abstract] [Full Text] [Related]
6. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe. Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996 [No Abstract] [Full Text] [Related]
16. In brief: Zetia and Vytorin: the ENHANCE study. Med Lett Drugs Ther; 2008 Jan; 50(1278):5. PubMed ID: 18219263 [No Abstract] [Full Text] [Related]
17. Is there a problem with ezetimibe or just ENHANCEd hype? Whayne TF Angiology; 2008 Dec-2009 Jan; 59(6):661-3. PubMed ID: 18796445 [No Abstract] [Full Text] [Related]
18. Heart protection study finds simvastatin reduces vascular risk in a wide range of high-risk patients. Collins R Am J Manag Care; 2002 Jan; Suppl():6. PubMed ID: 11833455 [No Abstract] [Full Text] [Related]
19. Where to draw the line using statins: lessons from 4S to AFCAPS/TexCAPS. Sprecher DL Cleve Clin J Med; 2000 Mar; 67(3):169-71. PubMed ID: 10743305 [No Abstract] [Full Text] [Related]
20. Cholesterol lowering after participation in the Scandinavian Simvastatin Survival Study (4S) in Finland. Strandberg TE; Lehto S; Pyörälä K; Kesäniemi A; Oksa H Eur Heart J; 1997 Nov; 18(11):1725-7. PubMed ID: 9402446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]